Swiss National Bank
CLCD

Swiss National Bank’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Swiss National Bank’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,200
Closed -$444K – 2546
2016
Q4 		$444K Buy
+12,200
New +$432K ﹤0.01% 2431

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Swiss National Bank's CLCD Position: Q1 2017 in Review

Swiss National Bank sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 12,200 shares — an estimated $444K sold.

Swiss National Bank first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $444K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Swiss National Bank reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Swiss National Bank sold 12,200 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $444K.
  • Swiss National Bank first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Swiss National Bank's CoLucid Pharmaceuticals, Inc. position peaked at $444K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.